Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy.
Delgrange
E
E
Donckier
J
J
D000634:Aminoquinolines / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D015175:Prolactinoma / Q000188:drug therapy*
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D018491:Dopamine Agonists; D004873:Ergolines; C046650:quinagolide; D000077465:Cabergoline